JOURNAL ARTICLE
An insight on medicinal attributes of pyrimidine scaffold: An updated review.
Published In: Journal of Heterocyclic Chemistry, 2023, v. 60, n. 7. P. 1081 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Vyas, Akshun; Sahu, Bhaskar; Pathania, Shelly; Nandi, Nilay Kumar; Chauhan, Gaurav; Asati, Vivek; Kumar, Bhupinder 3 of 3
Abstract
Pyrimidine itself or in different fused forms is an important chemical motif for every step of cell life. Alongside, it exists as a key pharmacophoric part in thiamine, alloxan, orotic acid, and other isoforms of nucleotide bases. It has emerged as a privileged scaffold in medicinal chemistry due to its various possible structural and pharmacological attributes. In a number of clinically used chemical agents, pyrimidine or its fused/clubbed form with other moieties act as a key pharmacophore. Structure activity relationship (SAR) studies of the explored derivatives demonstrated that slight modifications with various substitutions on the pyrimidine rings can deviate biological activity to a large extent. 2‐Pyrimidone and 2,4‐pyrimidione derivatives are largely explored by a number of research groups for various pharmacological targets and due to their similarity to nucleotide bases, it has a great impact on the biological profile of these molecules. The current review focuses on describing the recent advancements (2015 onward) in the development of pyrimidine‐based biologically active molecules along with drug candidates under different clinical trials. The aim of this review is to provide structural features associated with pyrimidine along with their SAR studies, which are believed to be valuable for the scientists working on the development of pyrimidine‐based small molecules in the aforementioned disease conditions. We believe that the results of this research will help to provide a structural idea that may be used in the design and development of new pyrimidine‐based small molecules that target a variety of receptors or enzymes. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Journal of Heterocyclic Chemistry. 2023/07, Vol. 60, Issue 7, p1081
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2023
- ISSN:0022-152X
- DOI:10.1002/jhet.4593
- Accession Number:164701137
- Copyright Statement:Copyright of Journal of Heterocyclic Chemistry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.